Pembrolizumab vs Trihexyphenidyl
Pembrolizumab vs Trihexyphenidyl: Overview
This comparison examines the pharmacological differences between Pembrolizumab and Trihexyphenidyl.
Mechanism of Action
Pembrolizumab: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.
Pharmacokinetics
Half-life: Pembrolizumab β 26 days.
Chemical Properties
Type: Pembrolizumab β Antibody; Trihexyphenidyl β Small molecule.